JD Health sees increase in issued share capital for November

JD Health International Inc. reported a notable increase in its total number of issued shares for the month ended 30 November 2025. The company’s issued ordinary shares, excluding treasury shares, rose from 3,201,475,111 to 3,209,275,111, reflecting an increase of 7,800,000 shares. This brings the total number of issued shares to 3,209,275,111, with no changes in treasury shares during the period. The authorised/registered share capital remained stable at $50,000, comprising 100,000,000,000 ordinary shares with a par value of $0.0000005 each.

The increase in issued shares primarily stems from the Post-IPO Share Award Scheme, adopted on 23 November 2020, which resulted in 7,800,000 new shares being issued during the month. Additionally, movements under the Pre-IPO ESOP (Exercise Price: $0.0000005) saw 11,323,410 options outstanding at the end of the month, down from 11,387,260, due to lapsed and other options. The exercise of Pre-IPO ESOP options did not lead to new share issuances as they were satisfied by existing shares held in trust.

The total funds raised from the exercise of options during the month amounted to $0.01. The company confirmed that all movements were duly authorised and complied with applicable listing rules and regulatory requirements.